A potential cause of psychiatrist ambivalence was provided in some of the postdialogue interviews in which some of the psychiatrists expressed concern that making an LAI recommendation might threaten the delicate therapeutic alliance with the patient. Although speculative in nature, it is also possible that psychiatrists’ bias to LAls may be, at least in part, determined by their initial experience with LAI therapies. The residency period, during which psychiatrists first experience with LAI therapies could have originated as a court-ordered inpatient treatment, may have affected their attitude toward LAIs. Such an experience could have contributed to enduring negative attitudes toward injectable treatments generally. Other possible reasons for the observed reluctance to make an offer of LAls include disruption of patient-flow dynamics of the treatment setting requirements for additional personnel, and other challenges arising from the management of injections in a busy practice. None of these reasons are mutually exclusive.